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Abstract 
Objective: To evaluate the hearing efficiency of Oral Submucous Fibrosis (OSF) patients using 
Pure Tone Audiometry (PTA) and to correlate between the hearing efficiency and clinical stage 
of OSF. Material and Methods: Twenty-five patients clinically diagnosed as OSF were 
evaluated for hearing loss using ‘PTA’. Patients were grouped as mild cases and severe cases. 
Mild cases comprised of Group A and B, and severe cases comprised of Group C and D. Patients 
suffering from the previous hearing were excluded from the study. The data were submitted to 
statistical evaluation using the Chi-square test. The level of significance was set at 5%. Results: 
Out of the total patients, 52.4% were diagnosed as mild cases (Group M) OSF and 47.6% as 
severe cases (Group S). The analysis of the data of mild cases and severe cases revealed a 
significant association between advancing stages of OSF and hearing loss (p = 0.026). The cases 
in Group M after otoscopic evaluation demonstrated no visible ear defect. However, 30% of cases 
in Group S showed retraction of the tympanic membrane. Conclusion: The results indicate an 
association between stages of OSF and hearing loss. With advancing stages of OSF, there may be 
involvement of muscles of soft palate namely the levator veli palatine or tensor veli palatine, 
which may lead to the narrowing of the Eustachian tube leading to a decrease in air conduction 
demonstrating it as hearing loss of varying degrees depending upon the involvement. 
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Introduction 
Oral submucous fibrosis (OSF) is a progressive disease of the oral cavity, which was named 
“vidari” by the Sushruta in 600 B.C [1]. It was first described in 1952 by Schwartz, who called it 
“atrophia idiopathica mucosae oris” [2]. Since then, its understanding along clinical and molecular 
levels have increased considerately. 
OSF is attributed to a variety of factors like betel nut alkaloids, capsaicin, hypersensitivity, 
autoimmunity, genetic predisposition, and chronic iron and vitamin B-complex deficiency, the major 
factor being areca nut [3]. Areca nut chewing is a common practice in the Indian subcontinent and 
retains its popularity as a masticatory even today. 
Pindborg defined OSF as “a chronic insidious disease, affecting any part of the oral cavity 
and sometimes the pharynx. Although occasionally preceded by and/or associated with vesicle 
formation, it is always associated with a juxta-epithelial inflammatory reaction followed by 
fibroelastic changes of the lamina propria, with epithelial atrophy leading to stiffness of the oral 
mucosa and causing trismus and inability to eat” [4]. 
OSF is regarded as a collagen disorder causing fibrosis, and these fibroelastic changes can 
extend posteriorly into soft palate and nasopharynx, causing difficulty in speech. It may also involve 
the pharyngeal orifice of the Eustachian tube and paratubal muscles, thereby affecting its functions 
and causing pain along with other pathological changes in the middle ear, which can eventually lead 
to hearing impairment. 
Pure Tone Audiometry (PTA) is an electronic device that produces pure tones and is the 
most common technique used for hearing assessment. It helps in identifying hearing threshold levels 
and also determines the type, degree, and configuration of hearing impairment [5-7]. The present 
study aimed to evaluate the hearing efficiency of OSF patients using PTA. 
 
Material and Methods 
Study Design and Sample 
A clinical cross-sectional study was undertaken in the authors’ institute after obtaining the 
institutional ethical clearance. Twenty-five clinically confirmed cases of OSF (ears) were evaluated 
and graded according to the Lai DR classification [8]. All patients were tested for air and bone 
conduction hearing loss. Four cases were excluded from the study as the patients had OSF with 
middle ear defects or sensorineural hearing deficit. Informed written consent was obtained from all 
participating patients. 
 
Data Collection 
The patients were then divided into two groups, Mild cases (Group M) which included the 
Group A and B and; Severe cases (Group S) which included Group C and D [8] (Figure 1). The 
patients were then subjected to middle ear evaluation using otoscopy and hearing function evaluation 
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using PTA. Apure tone audio was delivered to the ear through the headphone for assessing air 
conduction impairment while bone vibrator was used to evaluate bone conduction loss. 
 
 
Figure 1. Lai classification for OSF based on the inter-incisal distance [8]. (A) Group A: >35 mm inter-
incisal distance, (B) Group B: 30-35 mm inter-incisal distance, (C) Group C: 20-30 mm inter-incisal 
distance, and (D) Group D: <20 mm inter-incisal distance. 
 
The hearing loss is graded into several categories by air conduction threshold as; 10-15dB – 
normal hearing, 16-25 dB – minimal hearing loss, 26-40 dB – mild hearing loss, 41-55 dB – moderate 
hearing loss, 56-70 dB – moderate to severe hearing loss, 71-90 dB – severe hearing loss, and >90 dB 
– profound deafness [9]. The patients were scored depending on their hearing loss and ear 
involvement assessment and were interpreted as: 0: No hearing loss; 1: Mild hearing loss unilateral; 
2: Mild hearing loss bilateral; 3: Moderate hearing loss unilateral; 4: Moderate hearing loss bilateral; 
5: Moderate to severe hearing loss unilateral; 6: Moderate to severe hearing loss bilateral; 7: Severe 
hearing loss unilateral; 8: Severe hearing loss bilateral; and 9: Profound deafness. 
 
Data Analysis 
Data were tabulated and evaluated statistically using the Statistical Package for Social 
Service (SPSS) software for Microsoft Windows, version 17. The Pearson Chi-Square test was used 
to assess the association between hearing loss and different grades of OSF. The level of significance 
was set at 5%. 
 
Results 
Out of the total patients, 52.4% were diagnosed as mild cases (Group M) OSF and 47.6% as 
severe cases (Group S) of OSF, as shown in Table 1. In Group M OSF cases, 100% showed no 
hearing loss; whereas in Group S 40% cases showed no hearing loss, 20% showed mild hearing loss 
unilaterally, 30% showed mild hearing loss bilaterally, and 10% showed moderate hearing loss 
unilaterally. 
There was a significant association between OSF groups and hearing loss (p = 0.026). The 
cases in Group M after otoscopic evaluation demonstrated no visible ear defect. However, 30% of 
cases in Group S showed retraction of the tympanic membrane. 
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Table 1. Inter-group comparison between the hearing loss score and OSF groups. 
Score Stage Mild (A+B) Stage Severe (C+D) Total 
 N % N % N % 
0 11 73.3 4 26.7 15 71.4 
1 0 0.0 2 100.0 2 9.5 
2 0 0.0 3 100.0 3 14.3 
3 0 0.0 1 100.0 1 4.8 
Total 11 52.4 10 47.6 21 100.0 
 
In Figure 2, the inter-group comparison of hearing loss was interpreted. It showed that as 
the mouth opening reduced, the hearing efficiency also decreased, concluding a significant Pearson’s 
Rank correlations on comparison of the degree of mouth opening with hearing loss. 
 
 
Figure 2. Inter-group comparison of hearing loss. 
 
Discussion 
Oral Submucous Fibrosis is classified under Group 1 of potentially malignant disorders; 
suggestive of morphologically altered tissue in which external factor is responsible for etiology and 
malignant transformation [10,11]. It is a chronic, an insidious disabling disease involving oral 
mucosa, the oropharynx, and rarely larynx [3]. Various histopathological studies have established 
that OSF can affect the muscular tissue in advancing stages. 
The Eustachian tube is approximately 3 mm in diameter and can be divided into two parts: 
cartilaginous part (first two-thirds), bony part (last third, the part closest to the middle ear space). 
Narrowing of the pharyngeal orifice of the Eustachian tube might be seen in OSF, leading to the 
failure of the Eustachian tubes to regulate air pressure effectively [12-15]. This might cause 
sensations of popping, clicking, and ear fullness and occasionally moderate to severe ear pain. As 
Eustachian tube function worsens, air pressure in the middle ear falls, and the ear feels full, and 
sounds are perceived as muffled [9]. 
The present study revealed a positive association between the advancing grade of OSF and 
the Eustachian tube function defect. The results obtained were in accordance with previous studies 
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[6,9,16]. From the present study, it is evident that the subjective function of the Eustachian tube 
may be affected by the disease process. 
The limitations of this study were that the sample size was small; another limitation was that 
the present study design is a cross-sectional one, which makes it difficult to comment on any change 
in hearing status. 
 
Conclusion 
Oral Submucous Fibrosis is a potentially malignant disorder, affecting structures adjacent to 
the oral cavity. Hearing deficit is rarely noticed but might play the role of being an important factor 
for patient education for an explanation of the prognostic outcome of the condition. The 
management for the hearing deficit in cases of OSF should primarily involve the management of the 
condition, which requires habit cessation to prevent the further progression of the disease along with 
supportive care. The present study was on smaller sample size but can be further justified by studies 
involving a larger sample size and patients with severe OSF. 
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